Failure of Anti-CD20 Monoclonal Antibody Therapy to Prevent Antibody-Mediated Rejection in Three Crossmatch-Positive Renal Transplant Recipients

Transplantation Proceedings

Volumn 39, Issue 8, 2007, Pages 2565-2567

  Matignon, M ^a   Tagnaouti, M ^a   Audard, V ^a   Dahan, K ^a   Lang, P ^a   Grimbert, P ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; B LYMPHOCYTE; CADAVER KIDNEY; CASE REPORT; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOCYTOTOXICITY; MALE; PLASMAPHERESIS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROPHYLAXIS; T LYMPHOCYTE; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT FAILURE;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD20; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY TRANSPLANTATION; MALE; TREATMENT FAILURE;

EID: 35348881475     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.08.038     Document Type: Article

References (9)

1. Glotz D., Antoine C., and Duboust A. Antidonor antibodies and transplantation: how to deal with them before and after transplantation. Transplantation 79 (2005) S30
2. Gloor J.M., DeGoey S.R., Pineda A.A., et al. Overcoming a positive crossmatch in living-donor kidney transplantation. Am J Transplant 3 (2003) 1017
3. Stegall M.D., Gloor J., Winters J.L., et al. A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody. Am J Transplant 6 (2006) 346
4. Pescovitz M.D. Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action. Am J Transplant 6 (2006) 859
5. Salama A.D., and Pusey C.D. Drug insight: rituximab in renal disease and transplantation. Nat Clin Pract Nephrol 2 (2006) 221
6. Genberg H., Hansson A., Wernerson A., et al. Pharmacodynamics of rituximab in kidney allotransplantation. Am J Transplant 6 (2006) 2418
7. Schroder C., Azimzadeh A.M., Wu G., et al. Anti-CD20 treatment depletes B-cells in blood and lymphatic tissue of cynomolgus monkeys. Transpl Immunol 12 (2003) 19
8. Cartron G., Dacheux L., Salles G., et al. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene. Blood 99 (2002) 754
9. Looney R.J., Anolik J.H., Campbell D., et al. B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab. Arthritis Rheum 50 (2004) 2580